These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers. Borin MT; Ferry JJ; Forbes KK; Hughes GS J Clin Pharmacol; 1994 Jul; 34(7):774-81. PubMed ID: 7929873 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis. Johnson CA; Ateshkadi A; Zimmerman SW; Hughes GS; Craig WA; Carey PM; Borin MT Antimicrob Agents Chemother; 1993 Dec; 37(12):2650-5. PubMed ID: 8109931 [TBL] [Abstract][Full Text] [Related]
5. Effect of food on absorption of cefpodoxime proxetil oral suspension in adults. Borin MT; Forbes KK Antimicrob Agents Chemother; 1995 Jan; 39(1):273-5. PubMed ID: 7695323 [TBL] [Abstract][Full Text] [Related]
6. A review of the pharmacokinetics of cefpodoxime proxetil. Borin MT Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203 [TBL] [Abstract][Full Text] [Related]
7. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil. Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530 [TBL] [Abstract][Full Text] [Related]
8. Disposition of minoxidil in patients with various degrees of renal function. Halstenson CE; Opsahl JA; Wright CE; Fleishaker JC; Andreadis NA; Sobieraj J; Matzke GR J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment. Boike SC; Pue MA; Freed MI; Audet PR; Fairless A; Ilson BE; Zariffa N; Jorkasky DK Clin Pharmacol Ther; 1994 Apr; 55(4):418-26. PubMed ID: 8162668 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist. Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432 [TBL] [Abstract][Full Text] [Related]
11. Disposition of guanadrel in subjects with normal and impaired renal function. Halstenson CE; Opsahl JA; Abraham PA; Schwenk MH; Andreadis NA; Antal EJ; Matzke GR J Clin Pharmacol; 1989 Feb; 29(2):128-32. PubMed ID: 2715368 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses. Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526 [TBL] [Abstract][Full Text] [Related]
13. Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil. Couraud L; Andrews JM; Lecoeur H; Sultan E; Lenfant B J Antimicrob Chemother; 1990 Dec; 26 Suppl E():35-40. PubMed ID: 2292528 [TBL] [Abstract][Full Text] [Related]
14. Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil. Dumont R; Guetat F; Andrews JM; Sultan E; Lenfant B J Antimicrob Chemother; 1990 Dec; 26 Suppl E():41-6. PubMed ID: 2292529 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil. Borin MT; Hughes GS; Spillers CR; Patel RK Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine. Kees F; Wellenhofer M; Bröhl K; Grobecker H Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Kneer J; Tam YK; Blouin RA; Frey FJ; Keller E; Stathakis C; Luginbuehl B; Stoeckel K Antimicrob Agents Chemother; 1989 Nov; 33(11):1952-7. PubMed ID: 2610506 [TBL] [Abstract][Full Text] [Related]
18. Isepamicin disposition in subjects with various degrees of renal function. Halstenson CE; Kelloway JS; Affrime MB; Lin CC; Teal MA; Shapiro BE; Awni WM Antimicrob Agents Chemother; 1991 Nov; 35(11):2382-7. PubMed ID: 1804011 [TBL] [Abstract][Full Text] [Related]
19. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients. Muller-Serieys C; Bancal C; Dombret MC; Soler P; Murciano G; Aubier M; Bergogne-Berezin E Antimicrob Agents Chemother; 1992 Oct; 36(10):2099-103. PubMed ID: 1444291 [TBL] [Abstract][Full Text] [Related]